Solu-medrol and Gamma-glutamyltransferase decreased - a phase IV clinical study of FDA data

Summary:

No or too few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

No or too few reports are found.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is used in multiple sclerosis. Currently, eHealthMe is studying from 36,917 Solu-medrol users.

What is Gamma-glutamyltransferase Decreased?

Gamma-glutamyltransferase decreased is found to be associated with 245 drugs and 115 conditions by eHealthMe. Currently, we are studying 306 people who have Gamma-glutamyltransferase decreased.

Do you take Solu-medrol and have Gamma-glutamyltransferase decreased?

Check whether Gamma-glutamyltransferase decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Gamma-glutamyltransferase decreased and when was it recovered:

Gamma-glutamyltransferase decreased in Solu-medrol

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Gamma-glutamyltransferase decreased and drugs with ingredients of methylprednisolone sodium succinate

Alternative drugs to, pros and cons of Solu-medrol:

Solu-medrol (36,917 reports)

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gamma-glutamyltransferase decreased treatments and more:

Gamma-glutamyltransferase decreased (306 reports)

All the drugs that are associated with Gamma-glutamyltransferase decreased:

Gamma-glutamyltransferase decreased

All the conditions that are associated with Gamma-glutamyltransferase decreased:

Gamma-glutamyltransferase decreased

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Solu-medrol) and Solu-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.